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Abstract
Real Time RT-PCR developed in recent years represents an useful tool in the diagnosis of 
RNA viruses. In order to accurately quantify and normalize a RNA target,  efficiency of 
reverse-transcription  must  be  considered.  In  this  study  a  cRNA-standard  based 
quantitative  Real  Time  RT-PCR  have  been  developed  for  HRV  quantification  on 
bronchoalveolar  lavage  (BAL) specimens.  Results  has  been compared to  a  quantitative 
plasmid standard-based Real Time RT-PCR previously developed by us.
Large amount of pHRV was linearized and purified. Blunt ends were generated and cRNA 
production was carried out. Dilutions of cRNA were generated and dynamic range, intra- 
and  inter-test  variability,  sensitivity  and  limit  of  detection  were  evaluated.  Sixty-seven 
BAL, previously resulted positive to our plasmid standard-based method, were evaluated 
using cRNA-standard quantification. 
cRNA curve showed a broad dynamic range with a good intra- and inter-test variability, 
with an average of 3.23 threshold cycles more in comparison to plasmid standard-based 
curve. In terms of specimen quantification, a difference of 1.07log was found, showing a 
significant underrate using plasmid standard-based quantification.
The method for cRNA-standard construction seems more suitable  for quantification of 
RNA viruses, in order to normalize the quantification in reverse-transcription.
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Introduction
In recent years, a variety of techniques for measurement of the absolute concentration of 
specific RNA sequences have been developed, such as nucleic acid based-sequence 
amplification (NASBA), transcription-mediated amplification (TSA) and reverse 
transcription-PCR (RT-PCR) or Real Time RT-PCR. Among these methods, Real Time RT-
PCR is the most used and many platforms are available in the routine laboratories (1, 2, 3). 
In the assessment of a Real Time RT-PCR assay several factors have to be evaluated, such 
as efficiency of nucleic acids extraction, reverse-transcription and amplification, with this 
latter consisting of sensitivity, specificity (elsewhere defined as inclusivity and exclusivity), 
linearity, intra- and inter-test variability (or repeatability and reproducibility) (4). In 
literature, many Real Time RT-PCR assays are assessed using a plasmid-based standard 
curve, through their introduction in amplification step, thus generating an intrinsic error 
because of uncontrolled extraction and reverse transcription steps. At this regard, RNA 
could be most accurately and appropriately measured through the use of  reliable RNA 
preparations, calibrated to known concentrations as referred as cRNA standards (5, 6). 
The aim of this study was to develop an in vitro-transcribed cRNA-based standard method 
to quantify Human Rhinoviruses (HRV) by Real Time RT-PCR and to compare it with a 
plasmid-based standard method on bronchoalveolar lavage (BAL) specimens in terms of 
quantification capability, efficiency, sensitivity, linearity, detection limit, repeatability and 
reproducibility.
Materials and Methods
DNA plasmid standards were constructed as previously described (7). As regards cRNA 
standards, a large amount of HRV plasmid were obtained using PureLink™ HiPure 
Plasmid Midiprep Kit (Invitrogen, Carlsbad, USA) following manufactures’ instructions. 
Twelve micrograms of HRV-DNA plasmid was first linearized using SacI restriction 
enzyme (New England Biolabs, Inc., USA) at 37°C for 2h followed by inactivation at 65°C 
for 20 minutes. In order to avoid aspecific cutting inside of target sequence, digestion 
profile on Restriction mapper version 3 (available on line) was performed. Digested DNA 
was purified using Blood & Cell Culture DNA Mini Kit (Qiagen, Hiden, Germany) following 
manufactures’ instructions. DNA Polymerase I, Large (Klenow) Fragment (Invitrogen, 
Carlsbad, USA) was used to blunt DNA ends at 22°C for 15 minutes. cRNA production was 
carried out using T7-RiboMAX Large Scale RNA Production Systems (Promega, USA) at 
37°C for 4h. One-tenth of cRNA product was treated with RQ1 RNase-Free DNase 
(Promega, USA) at 37°C for 15 minutes followed by incubation with EDTA for 15 minutes 
at 65°C. HRV-cRNA was purified using RNAgent kit (Promega, USA) following 
manufactures’ instructions. HRV-cRNA was quantified using Quant-iT DNA BR Assay on 
Qubit™ fluorometer (Invitrogen, Carlsbad, USA). Ten-fold dilutions of cRNA were 
generated in order to amplify from 1010 to 100 copies per reaction. cRNA dilutions were 
extracted using NucliSens easyMAG platform (bioMerièux, Marcy l’Etoile, France) as well 
as biological samples. Viral ccDNA was generated, first by incubation of random primers 
(600ng/μl) and dNTPs (10mM) (Invitrogen) with 10μl of cRNA for 5 minutes at 70◦C. 
Subsequently, a mix containing buffer 5× [250mM Tris-HCl (pH 8.3 at 25°C), 375mM KCl 
and 50mM DTT], MgCl2 (25mM), ImpromII RT (1U/μl) and Recombinant RNasin® 
Ribonuclease Inhibitor (40 U/μl) (Promega) was added. The total volume (20μl) of the 
reaction mixture was incubated for 5 minutes at 25 ◦C, 60 minutes at 42 ◦C, 15 minutes at 
70 ◦C using 9800 Fast Thermal Cycler (Applied Biosystems, Monza, Italy). The RT-Real 
Time PCR was optimized using the final primers and probe concentrations of 250nM and 
125nM, respectively. Two microliters of ccDNA were added to 18μl of the reaction mix, 
giving a final reaction volume of 20μl using the thermal profile previously described (7). 
Different features were analyzed including the quantification capability, efficiency, 
sensitivity, linearity, detection limit, repeatability and reproducibility as described 
elsewhere (7).  A total of 67 BAL specimens were extracted using an automated extraction 
of combined DNA/RNA using NucliSens easyMAG platform (bioMerièux). RNA was 
extracted from 250:250 μl volume of clinical specimens:N-acetilcysteine, according to 
manufacturer’s instructions, and eluted to a final volume of 110μl. A total of 10μl of 
extracted RNA was subjected to reverse transcription following cRNA standards 
procedure. 
Results.
The main features of cRNA-based Real Time RT-PCR are reported on table 1. The assay 
was optimized by repeated testing of serial logarithmic dilutions of standard curve. The 
actual sensitivity of assay was determined by the lowest standard dilution consistently 
detectable in replicate reactions at a frequency of 100% and it was found to be 100 
copy/reaction and was linear (quantifiable) up to 102 copies. Linearity range was from 1010 
to 102 copies/reaction with a R2 index higher than 0.990. The efficiency of our cRNA-based 
Real Time RT-PCR assay was 1.91. The assay showed a good repeatability (CV % of 1.91 for 
102, 1.93 for 103, 1.10 for 104, 0.42 for 105) and reproducibility (CV % of 2.01 for 102, 2.12 for 
103, 1.92 for 104, 1.72 for 105). In table 1 differences among two Real Time RT-PCR assays 
are highlighted. As regards quantification capability, comparison among standard curves 
(plasmid-based versus cRNA-based) is reported in table 2. In particular, a mean difference 
of 3.23 Ct was highlighted, consisting in a right shift of cRNA-based standard curve 
compared to plasmid-based one, as reflected by the intercept values (38.42 for plasmid- 
versus 43.07 for cRNA-based standard curve). Sixty-seven bronchoalveolar lavages (BAL), 
previously resulted positive to HRV using plasmid-based standard curve Real Time RT-
PCR, were re-quantified using the developed cRNA-based standard curve. In terms of BAL 
quantification, a mean difference of 1.07 logarithm was observed. In terms of  
quantification capability, the use of plasmid-based standard curve lead to an overall 
underrate caused by the displacement.
Discussion
The development of a “in-house” Real Time RT-PCR assay, available for diagnostic routine, 
requires an analogous process applied to marked and approved commercial kit for 
diagnostic use (4, 8). This is realized by the standardization and optimization of the 
amplification protocol; however, also RNA extraction and reverse transcription protocols 
should be considered in the method assessment. At this regards, in this study an external 
in vitro synthesized cRNA standard is generated in order to obtain a calibration standard 
curve, thereby offering some advantages as control and standardization of RNA extraction 
and reverse transcription. The sensitivity of our assay was found to be of 100 copy/reaction 
with a linearity range from 1010 to 102 copies/reaction, characterized by a good efficiency, 
repeatability and reproducibility, comparable to those found in plasmid-based standard 
curve (7). Sensitivity parameter resulted one-logarithm lower in cRNA-based Real Time 
RT-PCR in comparison to plasmid-based Real Time RT-PCR, due to the displacement 
toward the right of cRNA standard curve that is also responsible for the difference in term 
of quantification. The use of plasmid-based standard curve lead to an overall underrate 
caused by the displacement of cRNA-based standards, as evidenced when considering 
intercepta values of standard curve equations. The displacement could be explained by the 
efficiency of nucleic acid extraction and reverse-transcription, the values of which are 
below to 100%, leading to a variable loss of initial RNA target amount. Considering that 
evaluation of the nucleic acid extraction and reverse-transcription efficiencies has a great 
impact on final quantification, this has to be taken into account in the assessment of a Real 
Time RT-PCR assay. While the efficiency of nucleic acid extraction is well documented and 
declared in manufacturer’s protocols, less informations are available about the efficiency of 
the reverse-transcription kits. Generally, the reverse transcription efficiency depends on 
many factors, including those RT enzyme-dependent (as presence of co-factors, salt 
concentrations and temperature) and those target-dependent (as initial RNA amount and 
RNA background) (9). Overall, the unique condicio sine qua non for cRNA standard 
synthesis is represented by the presence of a RNA polymerase promoter-binding site into 
the vector containing the amplicon of interest (many commercial products, comprising 
those used in our protocol, are characterized by the presence of T7-RNA polymerase 
promoter) and the choice of the in vitro transcription kit depends on it (5). On the other 
hand, the cRNA based method may present some limitations. As though RNA standards 
can be used, their stability could be a source of variability in the final analyses, thus 
requiring a thorough evaluation of nonconformities. In addition,  using RNA standards 
would involve the construction of cDNA plasmids that have to be in vitro transcribed into 
the RNA standards and accurately quantitated, which could be a time-consuming process. 
Nonetheless, the use of absolutely quantitated RNA standards will help generate absolute 
copy number data.
In conclusion, herein we evaluated two different approaches to HRV quantification by Real 
Time RT-PCR, using cRNA- and plasmid-based standard curves. Considering our results, 
the cRNA-based approach could be usefully applied for a more appropriate measurement 
of RNA viruses in biological samples. 
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Table 1. Main technical features of cRNA-based standard Real Time RT-PCR in 
comparison to plasmid-based standard Real Time RT-PCR.
Plasmid-
based 
standard 
curve 
cRNA-
based 
standard 
curve 
Linearity range  
(copies/reaction)
107-101 1010-102 
Sensitivity 10 100 
Limit of detection 10 100 
Efficiency 2.08 1.91
Ripetibility (CV%)
1 0.47 1.91
1 0.67 1.93
1 0.63 1.10
1
0
5
0.09 0.42
Reproducibility 
(CV%)
1 0.79 2.01
1 1.70 2.12
1 1.34 1.92
1
0
5
0.89 1.72
Table 2. Comparison of standard curves (plasmid-based versus cRNA-based) for HRV 
quantification by Real Time RT-PCR.
*Plasmid-based 
standard curve
**cRNA-
based 
standard 
curve
 (Ct)
102 32,11 36,96 3,85
103 28,95 32,74 3,79
104 25,79 28,75 2,96
105 22,64 25,55 2,91
* y=-3.16x+38.42 (R2=0.997); ** y=-3.56x+43.07 (R2=0.998)
